Despoina Kalapanida
Irakleion, ESYE43 71110, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Corrigendum: MicroRNAs regulating tumor immune response in the prediction of the outcome in patients with breast cancer.
Journal: Frontiers in molecular biosciences
Published: April 06, 2024
PD-L1 Gene Polymorphisms rs822336 G>C and rs822337 T>A: Promising Prognostic Markers in Triple Negative Breast Cancer Patients
Journal: Medicina (Kaunas, Lithuania)
Published: July 21, 2022
Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab.
Journal: Cancers
Published: July 12, 2022
MicroRNAs Regulating Tumor Immune Response in the Prediction of the Outcome in Patients With Breast Cancer.
Journal: Frontiers in molecular biosciences
Published: February 16, 2021
Prognostic role of microRNAs in breast cancer: A systematic review.
Journal: Oncotarget
Published: August 07, 2019
Prognostic significance of miR-34 rs4938723 T > C polymorphism in triple negative breast cancer patients.
Journal: Clinical biochemistry
Published: October 24, 2018
Evaluation of MET T1010I and MET rs40239 single-nucleotide polymorphisms in triple-negative breast cancer: a case-control study.
Journal: OncoTargets and therapy
Published: October 02, 2018
Lenalidomide with low- or intermediate-dose dexamethasone in patients with relapsed or refractory myeloma.
Journal: Leukemia & lymphoma
Published: February 27, 2016
TLR4/TIRAP polymorphisms are associated with progression and survival of patients with symptomatic myeloma.
Journal: British journal of haematology
Published: June 03, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026